SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,055,367 | +20.5% | 23,579 | +2.8% | 0.09% | -2.2% |
| Q3 2022 | $2,536,000 | +88.3% | 22,940 | +27.7% | 0.09% | +48.3% |
| Q2 2022 | $1,347,000 | -58.5% | 17,966 | -56.8% | 0.06% | -60.8% |
| Q1 2022 | $3,248,000 | +105.3% | 41,582 | +136.7% | 0.15% | +56.1% |
| Q4 2021 | $1,582,000 | +52.9% | 17,571 | +26.5% | 0.10% | +3.2% |
| Q1 2021 | $1,035,000 | +47.9% | 13,885 | +238.2% | 0.10% | +28.4% |
| Q4 2020 | $700,000 | -38.8% | 4,106 | -49.6% | 0.07% | 0.0% |
| Q3 2020 | $1,143,000 | -36.8% | 8,142 | -27.8% | 0.07% | -41.3% |
| Q2 2020 | $1,808,000 | -33.7% | 11,274 | -46.6% | 0.13% | -21.7% |
| Q4 2019 | $2,725,000 | +79.2% | 21,118 | +4.6% | 0.16% | +22.9% |
| Q3 2019 | $1,521,000 | +277.4% | 20,188 | +497.8% | 0.13% | +351.7% |
| Q1 2019 | $403,000 | -28.7% | 3,377 | -21.0% | 0.03% | -25.6% |
| Q2 2018 | $565,000 | +6.8% | 4,274 | -40.1% | 0.04% | +5.4% |
| Q1 2018 | $529,000 | +31.9% | 7,135 | -19.3% | 0.04% | -63.4% |
| Q3 2017 | $401,000 | -65.1% | 8,846 | -52.7% | 0.10% | -60.5% |
| Q3 2016 | $1,148,000 | +209.4% | 18,700 | -33.2% | 0.26% | +573.7% |
| Q1 2015 | $371,000 | +51.4% | 27,991 | +64.7% | 0.04% | -11.6% |
| Q4 2014 | $245,000 | – | 17,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |